Webb17 sep. 2024 · Protext Pharma @ProtextP $ TXTM is a # Biotech Co. developing a # cannabis medicines platform for legal # cannabisindustry, using proprietary live plant … Webb1 aug. 2024 · About Protext (OTC PINK: TXTM) Through its prior acquisitions, Protext has engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. Safe Harbor Statement
Protext Mobility Completes Name Change to Protext Pharma and …
WebbThe location of the apartment is unbeatable. Located on the second floor (with elevator) directly on the seafront. Supermarket, pharmacy, restaurants, boutiques ... everything is just a few steps away. An ideal starting point for excursions, walks on the beach, bike rides and boat trips. There are also free parking spaces. Webb3 apr. 2024 · TXTM Stock Overview. ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc. city \u0026 guilds reasonable adjustments
2-9-23 response to motion to consolidate 1 30 PM - Archive
Webb20 sep. 2024 · Protext Pharma operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. The Company is … Webb3 aug. 2024 · ProText Mobility, Inc. (OTCMKTS: TXTM) operating out of Aventura, Florida operates a number of wholly owned subsidiaries; Plandai Biotechnology South Africa (PTY) LTD. and Cannabis Biosciences, Inc. Plandai Biotechnology SA, has the exclusive worldwide license to develop pharmaceutical applications and products using the … Webb30 apr. 2024 · Johannesburg, South Africa--(Newsfile Corp. - April 30, 2024) - Republic of South Africa Medical Marijuana Dispensaries Pty Ltd. (RSAMMD) is pleased to announce it has executed a letter of intent with USA-based Protext Pharma, Inc. (OTC Pink: TXTM), a biotech company engaged in the development of pharmaceutical botanical medicines … city\u0026guilds secureassess familiarisation